SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-056598
Filing Date
2023-05-05
Accepted
2023-05-05 16:38:18
Documents
12
Period of Report
2023-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2313321d1_8k.htm   iXBRL 8-K 27337
  Complete submission text file 0001104659-23-056598.txt   200549

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA armp-20230501.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20230501_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20230501_pre.xml EX-101.PRE 22603
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2313321d1_8k_htm.xml XML 3474
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 23894518
SIC: 2836 Biological Products, (No Diagnostic Substances)